Drug Profile
Edonentan
Alternative Names: BMS 207940; BMS 207940-02Latest Information Update: 17 Jan 2008
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Heart failure therapies; Oxazoles; Sulfonamides
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure